The National Institute on Aging (NIA) Imbedded Pragmatic Alzheimer’s Disease (AD) and AD-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory is now accepting applications for its Career Development Award (CDA) program. These CDAs support the development of MD, PhD, or equivalent researchers who seek careers conducting embedded pragmatic clinical trials (ePCTs) for people living with AD/ADRD and their care partners.

The program will fund 2-year CDAs and will prioritize applications that address dementia care for people of all backgrounds and promote health equity. Each award will provide up to $220,000 in direct costs over 2 years with an indirect cost rate capped at 8%. Awardees are required to devote a minimum of 75% effort toward the goals of the award.

Eligible applicants include MD, PhD, or equivalent researchers who seek careers conducting ePCTs for people living with AD/ADRD and their care partners. Applicants are typically within 7 years of their postdoctoral training program at the time of application. Exceptions will be made in this round of funding for investigators with more than 7 years who can demonstrate evidence of changing their career path to pursue research on ePCTs among people living with dementia. Such applicants must request prior approval.

Applications are due Thursday, September 15, 2022. An informational webinar will be hosted on Wednesday, June 29, at 2:00 PM eastern to provide investigators with an overview of application details. Investigators will have the opportunity to ask questions. Use this link for required preregistration.

Learn more by reading answers to frequently asked questions regarding this award.